idursulfase
Selected indexed studies
- Idursulfase. (, 2006) [PMID:29999666]
- Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review. (Int J Mol Sci, 2024) [PMID:39201256]
- Idursulfase: I2S, iduronato-2-sulfatase. (Drugs R D, 2006) [PMID:16784250]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Idursulfase. (2006) pubmed
- Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review. (2024) pubmed
- Idursulfase: I2S, iduronato-2-sulfatase. (2006) pubmed
- Idursulfase in Hunter syndrome treatment. (2007) pubmed
- Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study. (2022) pubmed
- Idursulfase for the treatment of mucopolysaccharidosis II. (2008) pubmed
- Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). (2016) pubmed
- Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future. (2017) pubmed
- Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome). (2014) pubmed
- Efficacy and safety of idursulfase beta in the treatment of mucopolysaccharidosis II: A phase-3, 2-part study compared with a historical placebo cohort. (2025) pubmed